×
ADVERTISEMENT

capsaicin

Uncovering the Therapeutic Potential of High Concentration Capsaicin: Use of QUTENZA® (capsaicin) 8% Topical System For Managing Painful Symptoms Associated With Diabetic Peripheral Neuropathy of the Feet

This article is based on a symposium held at the 2023 annual meeting of the American Academy of Pain Medicine, and ...

AUGUST 7, 2023

Study Results Make Case for Capsaicin Patch As First-Line Postherpetic Neuralgia Agent

Two studies presented at the PAINWeek 2020 Live Virtual Conference suggest that the efficacy of the ...

FEBRUARY 10, 2021

FDA Accepts sNDA Filing for Capsaicin Patch DPNP Indication

The FDA has accepted a supplemental New Drug Application for capsaicin 8% patch for the treatment of neuropathic ...

JANUARY 15, 2020

Investigational Capsaicin Therapy After Bunionectomy Reduces Pain, Opioid Reliance

The novel, water-soluble prodrug CA-008, coupled with standard of care treatment, was found to significantly reduce ...

NOVEMBER 26, 2019

Load more